chr5-90716495-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_032119.4(ADGRV1):​c.9213C>T​(p.Asp3071=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00299 in 1,592,634 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 16 hom. )

Consequence

ADGRV1
NM_032119.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:10

Conservation

PhyloP100: 0.860
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 5-90716495-C-T is Benign according to our data. Variant chr5-90716495-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 46402.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2, Benign=5}. Variant chr5-90716495-C-T is described in Lovd as [Benign]. Variant chr5-90716495-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.86 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00305 (4392/1440442) while in subpopulation MID AF= 0.0178 (101/5676). AF 95% confidence interval is 0.015. There are 16 homozygotes in gnomad4_exome. There are 2219 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ADGRV1NM_032119.4 linkuse as main transcriptc.9213C>T p.Asp3071= synonymous_variant 43/90 ENST00000405460.9
LOC105379077XR_001742802.2 linkuse as main transcriptn.364-686G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ADGRV1ENST00000405460.9 linkuse as main transcriptc.9213C>T p.Asp3071= synonymous_variant 43/901 NM_032119.4 P1Q8WXG9-1

Frequencies

GnomAD3 genomes
AF:
0.00241
AC:
366
AN:
152074
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000773
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00353
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00360
Gnomad OTH
AF:
0.00431
GnomAD3 exomes
AF:
0.00255
AC:
620
AN:
242924
Hom.:
5
AF XY:
0.00290
AC XY:
381
AN XY:
131576
show subpopulations
Gnomad AFR exome
AF:
0.000716
Gnomad AMR exome
AF:
0.00172
Gnomad ASJ exome
AF:
0.00206
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00268
Gnomad FIN exome
AF:
0.000281
Gnomad NFE exome
AF:
0.00384
Gnomad OTH exome
AF:
0.00393
GnomAD4 exome
AF:
0.00305
AC:
4392
AN:
1440442
Hom.:
16
Cov.:
30
AF XY:
0.00311
AC XY:
2219
AN XY:
714574
show subpopulations
Gnomad4 AFR exome
AF:
0.00103
Gnomad4 AMR exome
AF:
0.00198
Gnomad4 ASJ exome
AF:
0.00169
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00304
Gnomad4 FIN exome
AF:
0.000284
Gnomad4 NFE exome
AF:
0.00331
Gnomad4 OTH exome
AF:
0.00372
GnomAD4 genome
AF:
0.00243
AC:
370
AN:
152192
Hom.:
2
Cov.:
33
AF XY:
0.00235
AC XY:
175
AN XY:
74412
show subpopulations
Gnomad4 AFR
AF:
0.000771
Gnomad4 AMR
AF:
0.00288
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00395
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.00360
Gnomad4 OTH
AF:
0.00427
Alfa
AF:
0.00294
Hom.:
0
Bravo
AF:
0.00248
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:6
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesAug 01, 2019- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024ADGRV1: BP4, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxAug 03, 2018- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 04, 2015- -
not specified Benign:4
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 06, 2020- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 20, 2012Asp3071Asp in exon 43 of GPR98: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, has been identified in 0.4% (26/6554) of Europe an American chromosomes and 0.01% (3/2960) of African American chromosomes in a broad population by the NHLBI Exome sequencing project (http://evs.gs.washington .edu/EVS/; dbSNP rs56329646). -
Usher syndrome type 2C Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
8.3
DANN
Benign
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56329646; hg19: chr5-90012312; COSMIC: COSV67983312; COSMIC: COSV67983312; API